Fingerprint
Dive into the research topics of 'Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model
Maria Virginia C. L. Appleyard, Mary A. O'Neill, Karen E. Murray, Fiona E. M. Paulin, Susan E. Bray, Neil M. Kernohan, David A. Levison, David P. Lane, Alastair M. Thompson
Research output: Contribution to journal › Article › peer-review
47
Citations
(Scopus)